CAJ | 학술논문

目的：研究参松养心胶囊联合美托洛尔治疗心律失常的临床疗效。方法选取2010年3月~2013年5月我院心内科收治的心率失常患者92例，采用随机数字表法将患者分成研究组与对照组，每组46例。对照组给予单独美托洛尔治疗，研究组给予参松养心胶囊联合美托洛尔治疗。观察两组患者治疗前后的血压、心率变化情况，2个月后统计分析两组的治疗效果。结果研究组患者治疗后显效26例，有效16例，无效4例，总有效率为91.3%；对照组治疗后显效18例，有效17例，无效11例，总有效率为76.1%。两组患者治疗的总有效率差异有统计学意义（P＜0.05）。与治疗前相比，研究组治疗后患者血压、心率的差异显著，均有统计学意义（P＜0.05）；研究组患者治疗后的血压、心率相对于对照组下降的幅度更为明显，两组之间的差异有统计学意义（P＜0.05）。结论参松养心胶囊联合美托洛尔能够更加有效的控制心律失常的心室率，临床效果显著，值得推广应用。
목적：연구삼송양심효낭연합미탁락이치료심률실상적림상료효。방법선취2010년3월~2013년5월아원심내과수치적심솔실상환자92례，채용수궤수자표법장환자분성연구조여대조조，매조46례。대조조급여단독미탁락이치료，연구조급여삼송양심효낭연합미탁락이치료。관찰량조환자치료전후적혈압、심솔변화정황，2개월후통계분석량조적치료효과。결과연구조환자치료후현효26례，유효16례，무효4례，총유효솔위91.3%；대조조치료후현효18례，유효17례，무효11례，총유효솔위76.1%。량조환자치료적총유효솔차이유통계학의의（P＜0.05）。여치료전상비，연구조치료후환자혈압、심솔적차이현저，균유통계학의의（P＜0.05）；연구조환자치료후적혈압、심솔상대우대조조하강적폭도경위명현，량조지간적차이유통계학의의（P＜0.05）。결론삼송양심효낭연합미탁락이능구경가유효적공제심률실상적심실솔，림상효과현저，치득추엄응용。
Objective To analyze clinical efficacy of Shensongyagnxin capsule combined with Metoprolol in the treatment of arrhythmia. Methods 92 cases of patients with arrhythmia were selected from March 2010 to May 2013 in cardiology department of arrhythmia in our hospital, which were randomly divided into two groups, each group had 46 cases. Control group was given Metoprolol therapy alone, treatment group was given Shensongyangxin capsule combined with Metoprolol therapy. Observed the blood pressure, heart rate before and after treatment carefully in both group, the treatment effect of the two groups were compared after 2 months. Results After the treatment, in the treatment group, 26 cases had marked effect, 16 cases effective,4 cases ineffective, the total effective rate was 91.3%. In the control group, 18 cases had marked effect, 17 cases effective, 11 cases ineffective, the total effective rate was 76.1%. The treatment effective rate between the two groups have statistical significance (P < 0.05). the treatment group blood pressure, heart rate compared with before treatment, the difference was statistically significant (P<0.05), compared with control group, the decline significantly, the difference was statistically significant(P<0.05). Conclusion Shensongyangxin capsule combined with Metoprolol arrhythmia id more effective to control ventricular rate. And it has significant clinical effect Clinical efficacy which is worthing to us in clinic.